UBS Group’s Baird Medical Investment Holdings BDMD Stock Holding History

UBS Group’s Portfolio BDMD Stock Details BDMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67.5K	Sell	58,687 -9,176	-14%	-$14.3K	﹤0.01%	7409
2026 Q1	$133K	Buy	67,863 +33,957	+100%	+$56.8K	﹤0.01%	6853
2025 Q4	$46.1K	Sell	33,906 -31,912	-48%	-$46.4K	﹤0.01%	7268
2025 Q3	$140K	Sell	65,818 -25,631	-28%	-$65.8K	﹤0.01%	6894
2025 Q2	$335K	Buy	91,449 +34,512	+61%	+$181K	﹤0.01%	6355
2025 Q1	$297K	Buy	56,937 +55,531	+3,950%	+$333K	﹤0.01%	6253
2024 Q4	$10.7K	Buy	+1,406	New	+$3.88K	﹤0.01%	8285

Other funds holding BDMD

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

UBS Group's BDMD Position: Q2 2026 in Review

UBS Group reduced its Baird Medical Investment Holdings (BDMD) stake by 14% in Q2 2026, selling an estimated $14.3K and leaving 58,687 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7409.

UBS Group first reported a position in BDMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $335K in Q2 2025. 6 funds tracked by Wall St. Rank hold BDMD as of Q2 2026.

UBS Group held 58,687 shares of Baird Medical Investment Holdings worth $67.5K as of Q2 2026.
UBS Group sold 9,176 Baird Medical Investment Holdings shares in Q2 2026, an estimated $14.3K.
Baird Medical Investment Holdings made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7409 holding.
UBS Group first reported a position in Baird Medical Investment Holdings in Q4 2024 and has held it in 7 quarters since.
UBS Group's Baird Medical Investment Holdings position peaked at $335K in Q2 2025.
6 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.